𝗪𝗲’𝗿𝗲 𝗼𝗻 𝗮 𝗥𝗼𝗹𝗹: 𝗧𝗵𝗲 𝗟𝘆𝗳𝗲𝗴𝗲𝗻 𝗟𝗶𝗯𝗿𝗮𝗿𝘆 𝗡𝗼𝘄 𝗛𝗮𝘀 𝟲,𝟬𝟬𝟬+ 𝗣𝘂𝗯𝗹𝗶𝗰 𝗔𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀! 🚀 Our 𝗹𝗶𝗯𝗿𝗮𝗿𝘆 𝗸𝗲𝗲𝗽𝘀 𝗴𝗿𝗼𝘄𝗶𝗻𝗴, and your access just got 6,000x smarter! We’ve now surpassed 𝟲,𝟬𝟬𝟬 𝗽𝘂𝗯𝗹𝗶𝗰 𝗱𝗿𝘂𝗴 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗸𝗲𝘆 𝗺𝗮𝗿𝗸𝗲𝘁𝘀, with major contributions from China and Brazil in full coverage. Plus, we’ve added updates from Switzerland, Denmark, the Netherlands, Finland, Australia, Italy, and Germany, along with ongoing updates for other countries. 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝗼𝘂𝘁—𝘁𝗵𝗶𝘀 𝗶𝘀 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗹𝗮𝗿𝗴𝗲𝘀𝘁 𝗣𝘂𝗯𝗹𝗶𝗰 𝗔𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀 𝗟𝗶𝗯𝗿𝗮𝗿𝘆, empowering you to discover, learn, and plan like never before. See how Lyfegen can help you accelerate access, enhance affordability, and save time & money. 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲—𝗮𝗰𝘁 𝗻𝗼𝘄 𝗮𝗻𝗱 𝗯𝗼𝗼𝗸 𝘆𝗼𝘂𝗿 𝗱𝗲𝗺𝗼 𝘁𝗼𝗱𝗮𝘆: https://hubs.la/Q02PhgbK0 #Lyfegen #HealthcareInnovation #RebateManagement #MarketAccess #ValueBasedHealthcare #PharmaceuticalPricing #HealthcareTechnology #DrugRebateSolutions #DigitalHealthcare #LyfegenLibrary #PatientOutcomes #RevenueOptimization
Lyfegen’s Post
More Relevant Posts
-
🌍 As the landscape of healthcare continues to evolve, understanding the implications of indication expansions on pricing and reimbursement is more critical than ever. Our latest research delves into how these expansions differ between the EU4 and UK markets, shedding light on the complexities and nuances that industry professionals must navigate. We're looking forward to presenting our findings at #ISPOREurope 2024, where Paul Craddy will share insights that can shape future strategies in market access. 🔍 Discover our findings at the poster discussion during Session 2 on 𝐌𝐨𝐧𝐝𝐚𝐲 𝟏𝟖𝐭𝐡 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫, at 𝟔:𝟎𝟎 𝐩𝐦 or meet us at 𝐛𝐨𝐨𝐭𝐡 𝟏𝟏𝟏𝟑. In the meantime, dive into our research abstract here 👉 https://lnkd.in/eWJjXEaj #MarketAccess #HEOR #ResearchInsights #Pharma #Healthcare
To view or add a comment, sign in
-
Thoughts on this? >> Hungary's Olivér Várhelyi readies to be EU health commissioner, pledging major pharma support >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Hungary's Olivér Várhelyi readies to be EU health commissioner, pledging major pharma support >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #biotech #pharmaceutical #pharma
Hungary's Olivér Várhelyi readies to be EU health commissioner, pledging major pharma support
endpts.com
To view or add a comment, sign in
-
Use of mainstream social media is on the rise among healthcare professionals! 41% of HCPs now consider it 'very important' for accessing scientific information, having risen from 33% in 2021. In these latest #EPGHealthResearch insights, we reveal which channels they choose to access most frequently. #MedicalAffairs #pharma #MedComms #HCPengagement
To view or add a comment, sign in
-
With the growing integration of mainstream social media in the healthcare sector, our medical educational programs are constantly adapting. We customize our communications not only according to demographics but also based on digital behaviors. This approach allows us to respond swiftly to the evolving needs and preferences of healthcare professionals. EPG Health has unveiled below the latest findings highlighting the channels most preferred by healthcare professionals for accessing scientific information. #HealthcareEducation #DigitalTransformation
Use of mainstream social media is on the rise among healthcare professionals! 41% of HCPs now consider it 'very important' for accessing scientific information, having risen from 33% in 2021. In these latest #EPGHealthResearch insights, we reveal which channels they choose to access most frequently. #MedicalAffairs #pharma #MedComms #HCPengagement
To view or add a comment, sign in
-
📖 What about Social Media and Healthcare Professionals? Do they use them at all for their practice? Interesting Data from EPG Health shows that according to their research, HealthCare Professionals use more and more #social #media to access specific scientific content to learn something new! What does it mean for scientific content providers? It's going to become more and more important to get data on HCP's behavior on #socialmedia and push scientific content to them, so they get the right #content, at the right time and for the right #HCP. Julien Delpech Axel Devige
Use of mainstream social media is on the rise among healthcare professionals! 41% of HCPs now consider it 'very important' for accessing scientific information, having risen from 33% in 2021. In these latest #EPGHealthResearch insights, we reveal which channels they choose to access most frequently. #MedicalAffairs #pharma #MedComms #HCPengagement
To view or add a comment, sign in
-
#GreenHealthWeek 🌍💚 We are excited to share the event: “Handelsblatt Pharma 2024” with you as part of our Green Health Week. Our Managing Director Laura Wamprecht will be a speaker at the Handelsblatt Annual Conference "Pharma 2024". She will give a keynote speech on: "The Green Added Value - how our reimbursement system can pave the way for green healthcare". The agenda promises an intriguing program, including numerous networking opportunities. 📅 When? on February 29 - March 1, 2024 📍 Where? in Berlin & virtual Against the backdrop of ongoing drug supply shortages, geopolitical risks, and regulatory changes at the European and national levels, many questions remain regarding how exactly the pharmaceutical sector in Germany can regain momentum. At the Handelsblatt Pharma Conference 2024, the organizers bring together key voices, connecting the industry with decision-makers from politics and healthcare to discuss the pressing issues facing the sector. #greenhealth #pharma2024 #healthcare #digitalhealth
To view or add a comment, sign in
-
Today marks a ground-breaking moment with the release of our study, "Beneath the Surface: Unravelling the True Value of Generic Medicines", conducted by the Generics Market Access Committee (GMAC) of Medicines for Europe and IQVIA. As we unveil the findings, we're set to reshape perceptions around generic medicines. Moving beyond the traditional view of cost savings, the study reveals the multifaceted value generics bring to healthcare systems. Ensuring affordability 💶 Fostering innovation 💡 Strengthening supply chains- 9 in 10 of Europe’s critical medicines list are generic medicines📦 Enhancing patient access across Europe- generic medicines account for 70% of treatment volume in Europe 🌍 Discover more on how generics are paving the way for a more resilient and sustainable healthcare future. Dive into the full study here: https://lnkd.in/ewvrqM3b We at Zentiva, as a pan-European company producing, developing, and delivering generic medicines to all generations, are proud to support such a study proving the real value of generics. #GenericsValue #HealthcareInnovation #Affordable #AccesstoHealthcare
To view or add a comment, sign in
-
The launch of "Beneath the Surface: Unravelling the True Value of Generic" is more than just the publication of another study; it's a testament to our commitment to transforming healthcare for the better. Conducted by IQVIA for GMAC of Medicines for Europe, this study underscores the invaluable role of generic medicines in delivering unparalleled value far beyond cost savings. As we delve into the economic, patient, supply chain, and innovative dimensions, let's champion the generics' cause together. They're not just a financial choice; they're a cornerstone of sustainable healthcare. Join me in exploring these insights and redefining the future of healthcare. At Zentiva we're delighted to see such studies highlighting the true value of generics, reflecting our mission to serve all generations with effective, accessible medicines. #LeadershipInHealthcare #GenericMedicine #SustainableHealth
Today marks a ground-breaking moment with the release of our study, "Beneath the Surface: Unravelling the True Value of Generic Medicines", conducted by the Generics Market Access Committee (GMAC) of Medicines for Europe and IQVIA. As we unveil the findings, we're set to reshape perceptions around generic medicines. Moving beyond the traditional view of cost savings, the study reveals the multifaceted value generics bring to healthcare systems. Ensuring affordability 💶 Fostering innovation 💡 Strengthening supply chains- 9 in 10 of Europe’s critical medicines list are generic medicines📦 Enhancing patient access across Europe- generic medicines account for 70% of treatment volume in Europe 🌍 Discover more on how generics are paving the way for a more resilient and sustainable healthcare future. Dive into the full study here: https://lnkd.in/ewvrqM3b We at Zentiva, as a pan-European company producing, developing, and delivering generic medicines to all generations, are proud to support such a study proving the real value of generics. #GenericsValue #HealthcareInnovation #Affordable #AccesstoHealthcare
To view or add a comment, sign in
-
It’s time to get creative to combat rising costs. When you’re planning your events, consider a change of scene to bypass cities commanding higher rates, think outside the box and explore venue options, and opt for a buffet over a banquet. For details and for more cost-conscious tips, visit https://bit.ly/48MU3NL to download our digital brochure. #healthcare #pharma #biotech #healthcaremeetings #medicalmeetings #lifesciencesmeetings #medicalevents #meetingplanners #eventplanners
To view or add a comment, sign in
24,555 followers